×
Site Menu
Everything
International
Politics
Local
Finance
Sports
Entertainment
Lifestyle
Technology
Literature
Science
Health
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
1 month ago
64
A Biogen facility in Cambridge, Massachusetts.
Brian Snyder | Reuters
Biogen
Read Entire Article
Homepage
Finance
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Related
Chipotle is opening its first restaurant in Mexico
11 hours ago
7
Paramount-WBD merger expected to face lawsuit from multiple ...
17 hours ago
7
Big banks poised to report booming revenue propelled by Spac...
19 hours ago
7
RIGHT SIDEBAR TOP AD
Trending
Popular
Reform UK’s Farage resigns as MP amid funding scandal, forci...
6 days ago
39
Deadly strikes in Gaza leave 5 dead, children wounded
5 days ago
36
‘Not Nigel Farage’: Who is Count Binface, contesting as MP f...
4 days ago
31
US moves to delist Syria as a ‘state sponsor of terrorism’
5 days ago
29
Florida's Palm Beach airport renamed for Trump
4 days ago
26
RIGHT SIDEBAR BOTTOM AD